Medicine and Dentistry
Lung Cancer
100%
COVID-19
53%
Lung Transplantation
53%
Primary Graft Dysfunction
50%
Segmentectomy
50%
Acute Respiratory Distress Syndrome
40%
Lung
36%
Cytokine
33%
Progenitor Cell
33%
Esophagectomy
33%
Odds Ratio
30%
Lobectomy
26%
Clinical Stage
25%
Anesthesiologist
22%
Bronchiolitis Obliterans
22%
Surgeon
20%
Silo-Filler's Disease
19%
Extracorporeal Membrane Oxygenation
18%
Postoperative Complication
17%
Collagen Type 1
17%
Hernia
16%
Lavage
16%
Lung Artery Pressure
16%
Adjuvant Chemotherapy
16%
Hepatectomy
16%
Infection
16%
Peptoclostridium difficile
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Systematic Review
16%
Pneumonectomy
16%
Ambulatory Surgery
16%
Allograft
16%
Bronchoscopy
16%
Lung Nodule
16%
Complement Deposition
16%
Acute Respiratory Failure
16%
Chronic Respiratory Failure
16%
Malignant Neoplasm
16%
Neoplasm
15%
Pulmonary Disorder
14%
Colectomy
14%
Clara Cell
13%
Secretory Protein
13%
Hazard Ratio
13%
Stem Cell
13%
Overall Survival
12%
Cystic Fibrosis
11%
In Vitro
11%
Growth Factor
11%
Cell Growth
11%
Keyphrases
Non-small Cell Lung Cancer (NSCLC)
55%
Lung Transplantation
54%
Primary Graft Dysfunction
51%
COVID-19
50%
Segmentectomy
40%
Acute Respiratory Distress Syndrome
37%
Confidence Interval
33%
Resectable Lung Cancer
33%
Lung Cancer
33%
Minimally Invasive Esophagectomy
33%
Fibrocytes
22%
Lobectomy
22%
Operative Time
21%
End-stage Lung Disease
21%
Clinical Characteristics
21%
Progenitor Cells
20%
Resection
20%
Patients with COVID-19
20%
Open Esophagectomy
19%
Rural Areas
19%
Survival Outcomes
19%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
18%
Esophagectomy
18%
Surgically Treated
18%
Postoperative Complications
17%
Early Rescue
16%
Clinical Outcomes
16%
Pulmonary Artery Pressure
16%
ALPPS
16%
Potentially Resectable
16%
Adjuvant Chemotherapy
16%
Lung Allograft
16%
Complement Deposition
16%
Travel Distance
16%
Temporal Correlation
16%
Surgical Volume
16%
Subsolid Pulmonary Nodule
16%
Chemical Localization
16%
Paraconduit Hernia
16%
Bone Marrow Progenitor Cells
16%
Survival Disparities
16%
SARS-CoV-2 Infection
16%
National Trends
16%
Surgeons
16%
Ambulatory Surgery
16%
Novel Treatments
16%
Robotic Bronchoscopy
16%
Severe Clostridium Difficile
16%
Lavage
16%
Early-stage Lung Cancer
16%
